文献速递复苏、休克与脓毒症心脑血管急症

伊伐布雷定诱导的心率减慢加重大鼠心肺复苏后心肌功能障碍

IVABRADINE-INDUCED HEART RATE REDUCTION INCREASES THE SEVERITY OF POSTRESUSCITATION MYOCARDIAL DYSFUNCTION IN A RAT MODEL OF CARDIOPULMONARY RESUSCITATION.
PubMed 文献 · Shock · 2022-10-31
一句话结论大鼠CPR模型中,复苏后1小时给予伊伐布雷定(0.5 mL/kg)减慢心率,会加重复苏后心肌功能障碍并缩短生存时间。

研究在Sprague-Dawley大鼠中实施6分钟心室颤动和8分钟心肺复苏,将32只复苏成功动物随机分为生理盐水组和伊伐布雷定组(每组含非生存和生存亚组,各n=8)。复苏后1小时给予生理盐水或伊伐布雷定(0.5 mL/kg)。伊伐布雷定组实现稳定心率减慢(Δ≈-30 bpm,相对比例≈-7.4%),但复苏后心肌功能显著更差(均P<0.01),心率变异性显著受损(均P<0.05),血清心肌肌钙蛋白I和肾上腺素浓度显著更高(均P<0.01),生存时间显著缩短(388 vs. 526 min,P<0.01)。作者结论认为伊伐布雷定诱导的心率减慢加重复苏后心肌功能障碍并缩短生存时间。

要点

  • 大鼠CPR模型中,复苏后1小时给予伊伐布雷定0.5 mL/kg实现稳定心率减慢(Δ≈-30 bpm,相对比例≈-7.4%),较生理盐水组P<0.01。
  • 伊伐布雷定组复苏后心肌功能(心输出量、射血分数、心肌性能指数)显著更差,均P<0.01。
  • 伊伐布雷定组心率变异性显著受损(均P<0.05),血清心肌肌钙蛋白I和肾上腺素浓度显著更高(均P<0.01)。
  • 伊伐布雷定组生存时间较生理盐水组显著缩短(388 vs. 526 min,P<0.01)。
  • 复苏后心率较基线平均升高Δ≈+15 bpm(相对比例≈+3.8%), resultant HR 405 bpm持续超过5小时。

适用人群与场景

  • Sprague-Dawley大鼠,经历6分钟心室颤动和8分钟心肺复苏后复苏成功的动物(共32只)。

处置流程与药物剂量

  • 复苏后1小时给予伊伐布雷定0.5 mL/kg(腹腔注射途径原文未写明)。
  • 复苏后1小时给予生理盐水(对照组)。

研究设计与关键结果

  • 研究类型:大鼠心肺复苏模型实验;样本量:32只复苏成功大鼠,随机分为生理盐水组和伊伐布雷定组,每组含非生存和生存亚组(各n=8)。
  • 干预与对照:复苏后1小时给予伊伐布雷定(0.5 mL/kg)或生理盐水。
  • 主要终点:伊伐布雷定组较生理盐水组实现稳定心率减慢(Δ≈-30 bpm,相对比例≈-7.4%,P<0.01)。
  • 关键次要终点:复苏后心肌功能伊伐布雷定组显著更差(均P<0.01);心率变异性伊伐布雷定组显著受损(均P<0.05);血清心肌肌钙蛋白I和肾上腺素浓度伊伐布雷定组显著更高(均P<0.01);生存时间伊伐布雷定组较生理盐水组显著缩短(388 vs. 526 min,P<0.01)。
  • 基线心率约390 bpm;复苏后平均升高Δ≈+15 bpm(相对比例≈+3.8%),心率达405 bpm并持续超过5小时。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠心肺复苏模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:伊伐布雷定诱导的心率减慢加重复苏后心肌功能障碍并缩短生存时间,在大鼠CPR模型中。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Aims: A rapid heart rate (HR) that occurs after cardiopulmonary resuscitation (CPR) is a short-term compensatory mechanism preserving cardiac output. However, if of long duration, it is unfavorable for myocardial function postresuscitation because of disrupted balance between myocardial oxygen supply and demand. This raises the assumption that such a sustained fast HR should be regulated. The present study aimed to investigate the follow-on effect of ivabradine (a specific inhibitor of the I f current of the sinoatrial node)-induced HR reduction (HRR) on postresuscitation myocardial function in a rat model of CPR. Methods and results: Six minutes of ventricular fibrillation and 8 min of CPR were performed on Sprague-Dawley rats. All 32 resuscitated animals were then randomized into saline and ivabradine groups, each group having nonsurvival and survival subgroups (n = 8 each). Saline or ivabradine (0.5 mL/kg) was administered at 1 h postresuscitation. Heart rate, myocardial function as expressed by cardiac output, ejection fraction, and myocardial performance index were assessed at baseline and hourly from 1 to 5 h postresuscitation. Heart rate variability was analyzed at baseline and at 1, 3, and 5 h postresuscitation. Serum epinephrine and cardiac troponin I at baseline and at 1, 3, and 5 h postresuscitation in nonsurvival subgroup were measured. Survival duration in the survival subgroup was observed. The baseline HR was approximately 390 beats/min (bpm). After resuscitation, an average increase of Δ ≈ +15 bpm (relative ratio ≈ +3.8%) with a resultant HR of 405 bpm lasting more than 5 h occurred. Ivabradine group achieved a steady HRR of Δ ≈ -30 bpm (relative ratio ≈ -7.4%) as compared with saline group ( P < 0.01). Postresuscitation myocardial function was significantly worse in the ivabradine group (all P < 0.01). Heart rate variability was significantly impaired in the ivabradine group (all P < 0.05). Serum cardiac troponin I and epinephrine concentration were significantly higher in the ivabradine group (all P < ?0.01). Survival duration was significantly shortened in the ivabradine group as compared with the saline group (388 vs. 526 min, P < ?0.01). Conclusions: Ivabradine-induced HRR increases the severity of postresuscitation myocardial dysfunction and shortens survival duration in a rat model of CPR.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Hu Z, Gao S, Yang J, et al. IVABRADINE-INDUCED HEART RATE REDUCTION INCREASES THE SEVERITY OF POSTRESUSCITATION MYOCARDIAL DYSFUNCTION IN A RAT MODEL OF CARDIOPULMONARY RESUSCITATION. Shock. 2022. PMID: 36548647. doi:10.1097/SHK.0000000000002020

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。